|
FRYL expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.59360000143261E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.33559999995858E-06 |
| Normal-vs-Stage2 |
4.09369999998521E-06 |
| Normal-vs-Stage3 |
1.45880000002041E-06 |
| Normal-vs-Stage4 |
9.2549001795561E-10 |
| Stage1-vs-Stage2 |
2.011000E-01 |
| Stage1-vs-Stage3 |
2.025800E-01 |
| Stage1-vs-Stage4 |
8.785500E-04 |
| Stage2-vs-Stage3 |
7.897200E-01 |
| Stage2-vs-Stage4 |
1.894970E-01 |
| Stage3-vs-Stage4 |
6.756500E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.321300000523E-07 |
| Normal-vs-AfricanAmerican |
3.770700E-04 |
| Normal-vs-Asian |
1.297460E-03 |
| Caucasian-vs-AfricanAmerican |
8.549400E-01 |
| Caucasian-vs-Asian |
4.177800E-01 |
| AfricanAmerican-vs-Asian |
4.714400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.21040000022887E-07 |
| Normal-vs-Female |
1.2918000003026E-07 |
| Male-vs-Female |
7.004800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.41679999999356E-05 |
| Normal-vs-Age(41-60Yrs) |
1.09979999995957E-07 |
| Normal-vs-Age(61-80Yrs) |
6.21560000135801E-08 |
| Normal-vs-Age(81-100Yrs) |
1.901650E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.066370E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.430000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.770400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.495400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.122800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.911600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.674000E-01 |
| Classical-VS-Follicular |
4.561400E-03 |
| Classical-VS-Other |
4.094400E-01 |
| Classical-VS-Normal |
2.72310000004605E-06 |
| Tall-VS-Follicular |
5.361200E-01 |
| Tall-VS-Other |
8.322600E-01 |
| Tall-VS-Normal |
3.170600E-04 |
| Follicular-VS-Other |
8.942800E-01 |
| Follicular-VS-Normal |
1.43790000017852E-07 |
| Other-VS-Normal |
1.694040E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.49629999793788E-08 |
| Normal-vs-N1 |
6.85790000010122E-07 |
| N0-vs-N1 |
5.954200E-01 |
|
|
